Peter Chin

Chief Tech/Sci/R&D Officer at DENALI THERAPEUTICS INC.

Net worth: 4 M $ as of 31/05/2026

58 year

Health Technology

Consumer Services

Profile

Peter Chin is currently Chief Medical Officer & Head-Development at Denali Therapeutics, Inc. since 2025.
Education includes a doctorate from Geisel School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
DENALI THERAPEUTICS INC. 0.13%	10/04/2026	204,402 ( 0.13% )	4 M $	31/05/2026

Peter Chin active positions

Companies	Position	Start
DENALI THERAPEUTICS INC.	Chief Tech/Sci/R&D Officer	06/11/2025

All active positions of Peter Chin

Training of Peter Chin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Chin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Denali Therapeutics, Inc. Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases	Health Technology
Geisel School of Medicine Geisel School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services